Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorOgan, Nalan
dc.contributor.authorSayın, Refah
dc.contributor.authorBaha, Ayşe
dc.contributor.authorAkpinar, Evrim Eylem
dc.contributor.authorGülhan, Meral
dc.date.accessioned2021-11-01T18:18:18Z
dc.date.available2021-11-01T18:18:18Z
dc.date.issued2019
dc.identifier.issn2149-3189
dc.identifier.issn2149-3189
dc.identifier.urihttps://doi.org10.18621/eurj.367066
dc.identifier.urihttps://app.trdizin.gov.tr/makale/TkRBek5EVXdNQT09
dc.identifier.urihttps://hdl.handle.net/11491/8004
dc.description.abstractObjective: Chronic Obstructive Pulmonary Disease (COPD) is accompanied by several concomitant conditions due to its systemic effects. Hypoxia and oxidative stress associated with COPD are also believed to contribute to the disease course through the effects of several inflammatory mediators. Major causative agents causing of peripheral neuropathy are age, hypoxia, duration and severity of COPD, hypercapnia and smoking. The present study aimed to investigate the incidence of polyneuropathy and its relation with disease parameters in COPD patients. Methods: Of a total number of 45 patients who had been followed up between January 1, 2015 and December 31, 2016 with a diagnosis of COPD at Ufuk University School of Medicine were enrolled retrospectively. All patients underwent electroneuromyography, arterial blood gas measurements and pulmonary function tests. Patients were divided as those with or without neuropathy, and factors contributing to the development of neuropathy were investigated based on clinical and laboratory findings. Results: Eleven (24.4%) patients were women and 34 (74.6%) were men, and the mean age was 73.2 years. Mean PaO2 was 58.2 mmHg, pCO2 was 41.2 mmHg, and FEV1 was 45.3%. Neuropathy was diagnosed in twenty (44.4%) patients. Significant differences were found in pO2, pCO2, SO2, mMRC, smoking status and number of exacerbations per year (p < 0.05). Conclusions: Patients who experience frequent exacerbations and those with hypoxemia or hypercapnia as demonstrated should be taken into more careful clinical assessments with respect to polyneuropathy.en_US
dc.language.isoengen_US
dc.relation.ispartofThe European Research Journalen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleThe incidence of polyneuropthy and its relation with disease parameters in chronic obstructive pulmonary diseaseen_US
dc.typearticleen_US
dc.department[Belirlenecek]en_US
dc.identifier.volume5en_US
dc.identifier.issue1en_US
dc.identifier.startpage77en_US
dc.identifier.endpage82en_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempUfuk Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Ankara, Türkiye;Ufuk Üniversitesi, Tıp Fakültesi, Nöroloji Anabilim Dalı, Ankara, Türkiye;Ufuk Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Ankara, Türkiye;Ufuk Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Ankara, Türkiye;Hitit Üniversitesi, Tıp Fakültesi, Göğüs Hastalıkları Anabilim Dalı, Çorum, Türkiyeen_US
dc.contributor.institutionauthor[Belirlenecek]
dc.identifier.doi10.18621/eurj.367066


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster